Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature
Only some cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. In the period May 2021 - February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 pa...
Saved in:
Main Authors: | Stefano Veraldi (Author), Vinicio Boneschi (Author), Marco Cusini (Author), Carlo Alberto Maronese (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
by: Francesco Drago, MD, et al.
Published: (2022) -
Pityriasis rosea and pityriasis rosea-like eruption: The distinction is relevant for diagnostic and prognostic reasons
by: Giulia Ciccarese, et al.
Published: (2024) -
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
by: Potestio L, et al.
Published: (2024) -
Vaccine-induced pityriasis rosea and pityriasis rosea-like Eruptions: A review of literature and a case report of COVID-19 vaccine-induced pityriasis rosea
by: Eman Almukhadeb, et al.
Published: (2022) -
Pityriasis rosea-like drug eruption secondary to deucravacitinib
by: Nisal Punchihewa, MD, et al.
Published: (2024)